Literature DB >> 22828146

Development of a novel murine model of aortic aneurysms using peri-adventitial elastase.

Castigliano M Bhamidipati1, Gaurav S Mehta, Guanyi Lu, Christopher W Moehle, Carlos Barbery, Paul D DiMusto, Adriana Laser, Irving L Kron, Gilbert R Upchurch, Gorav Ailawadi.   

Abstract

BACKGROUND: Our aim was to establish a novel model of abdominal aortic aneurysms (AAA) in mice using application of peri-adventitial elastase.
METHODS: C57BL/6J male mice underwent infrarenal peri-adventitial application of either (1) sodium chloride (control; n = 7), (2) porcine pancreatic elastase (PPE; n = 14), or (3) PPE and doxycycline (PPE + doxycycline 200 mg/kg; n = 11) for 14 days. Aortas were analyzed by video micrometry, immunohistochemistry, qualitative polymerase chain reaction, and zymography. Groups underwent Mann-Whitney U comparisons.
RESULTS: At day 14 compared with baseline, control animals had minimal aortic dilation, whereas fusiform aneurysms were seen in PPE (control, 20 ± 3%; PPE, 82 ± 15%; P ≤ .003). Doxycycline abrogated aneurysm formation (PPE, 82 ± 15%; PPE + doxycycline, 37 ± 10%; P ≤ .03). Compared with control and PPE + doxycycline, immunohistochemistry demonstrated greater elastin fiber degradation, macrophage infiltration, and matrix metalloproteinase-9 expression in PPE. Ki-67 and cleaved caspase-3 were lower in control versus PPE. The loss of smooth muscle marker expression seen with PPE was preserved in PPE + doxycycline. Zymography confirmed that both MMP-2 and -9 were more active in PPE than PPE + doxycycline.
CONCLUSION: Peri-adventitial application of elastase is a simple, reproducible in vivo model of aneurysm formation leading to consistent infrarenal aortic aneurysm development by day 14, with inflammatory cell infiltration and MMP upregulation. Doxycycline inhibits AAA progression in this model via limiting matrix degradation and preserving differentiated smooth muscle cells.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22828146      PMCID: PMC3601193          DOI: 10.1016/j.surg.2012.02.010

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  27 in total

Review 1.  Current concepts in the pathogenesis of abdominal aortic aneurysm.

Authors:  Gorav Ailawadi; Jonathan L Eliason; Gilbert R Upchurch
Journal:  J Vasc Surg       Date:  2003-09       Impact factor: 4.268

2.  Doxycycline in patients with abdominal aortic aneurysms and in mice: comparison of serum levels and effect on aneurysm growth in mice.

Authors:  Amy K Prall; G Matthew Longo; William G Mayhan; Eugene A Waltke; Beverly Fleckten; Robert W Thompson; B Timothy Baxter
Journal:  J Vasc Surg       Date:  2002-05       Impact factor: 4.268

3.  Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms.

Authors:  Michael W Manning; Lisa A Cassis; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-01-30       Impact factor: 8.311

4.  Elastase-induced experimental aneurysms in rats.

Authors:  S Anidjar; J L Salzmann; D Gentric; P Lagneau; J P Camilleri; J B Michel
Journal:  Circulation       Date:  1990-09       Impact factor: 29.690

5.  Adaptive cellular immunity in aortic aneurysms: cause, consequence, or context?

Authors:  John A Curci; Robert W Thompson
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

6.  Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms.

Authors:  G Matthew Longo; Wanfen Xiong; Timothy C Greiner; Yong Zhao; Nicola Fiotti; B Timothy Baxter
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

7.  Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice.

Authors:  Kiran Saraff; Fjoralba Babamusta; Lisa A Cassis; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-07-10       Impact factor: 8.311

Review 8.  Mouse models of abdominal aortic aneurysms.

Authors:  Alan Daugherty; Lisa A Cassis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-01-22       Impact factor: 8.311

9.  Doxycycline treatment in a model of early abdominal aortic aneurysm.

Authors:  Keiko Kaito; Hiroshi Urayama; Go Watanabe
Journal:  Surg Today       Date:  2003       Impact factor: 2.549

10.  Early MT-1 MMP expression following elastase exposure is associated with increased cleaved MMP-2 activity in experimental rodent aortic aneurysms.

Authors:  Indranil Sinha; Kevin K Hannawa; Jonathan L Eliason; Gorav Ailawadi; Michael P Deogracias; Siddharth Bethi; John W Ford; Karen J Roelofs; Vladimir Grigoryants; Peter K Henke; James C Stanley; Gilbert R Upchurch
Journal:  Surgery       Date:  2004-08       Impact factor: 3.982

View more
  33 in total

1.  A Novel Murine Model of Marfan Syndrome Accelerates Aortopathy and Cardiomyopathy.

Authors:  Nicholas B Cavanaugh; Lan Qian; Nicole M Westergaard; William J Kutschke; Ella J Born; Joseph W Turek
Journal:  Ann Thorac Surg       Date:  2017-03-27       Impact factor: 4.330

2.  Correlation of Wall Microstructure and Heterogeneous Distributions of Strain in Evolving Murine Abdominal Aortic Aneurysms.

Authors:  John S Wilson; Matthew R Bersi; Guangxin Li; Jay D Humphrey
Journal:  Cardiovasc Eng Technol       Date:  2017-04-04       Impact factor: 2.495

3.  Murine ultrasound-guided transabdominal para-aortic injections of self-assembling type I collagen oligomers.

Authors:  Alexa A Yrineo; Amelia R Adelsperger; Abigail C Durkes; Matthew R Distasi; Sherry L Voytik-Harbin; Michael P Murphy; Craig J Goergen
Journal:  J Control Release       Date:  2017-01-24       Impact factor: 9.776

4.  BAF60a Deficiency in Vascular Smooth Muscle Cells Prevents Abdominal Aortic Aneurysm by Reducing Inflammation and Extracellular Matrix Degradation.

Authors:  Ziyi Chang; Guizhen Zhao; Yang Zhao; Haocheng Lu; Wenhao Xiong; Wenying Liang; Jinjian Sun; Huilun Wang; Tianqing Zhu; Oren Rom; Yanhong Guo; Yanbo Fan; Lin Chang; Bo Yang; Minerva T Garcia-Barrio; Jiandie D Lin; Y Eugene Chen; Jifeng Zhang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-08-13       Impact factor: 8.311

5.  B2 cells suppress experimental abdominal aortic aneurysms.

Authors:  Akshaya K Meher; William F Johnston; Guanyi Lu; Nicolas H Pope; Castigliano M Bhamidipati; Daniel B Harmon; Gang Su; Yunge Zhao; Coleen A McNamara; Gilbert R Upchurch; Gorav Ailawadi
Journal:  Am J Pathol       Date:  2014-09-03       Impact factor: 4.307

6.  Effects of Iliac Stenosis on Abdominal Aortic Aneurysm Formation in Mice and Humans.

Authors:  Gurneet S Sangha; Albert Busch; Andrea Acuna; Alycia G Berman; Evan H Phillips; Matthias Trenner; Hans-Henning Eckstein; Lars Maegdefessel; Craig J Goergen
Journal:  J Vasc Res       Date:  2019-07-04       Impact factor: 1.934

7.  High-frequency murine ultrasound provides enhanced metrics of BAPN-induced AAA growth.

Authors:  Daniel J Romary; Alycia G Berman; Craig J Goergen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-09-27       Impact factor: 4.733

8.  Illuminating the Importance of Studying Interventions on the Propagation Phase of Experimental Mouse Abdominal Aortic Aneurysms.

Authors:  Hong S Lu; A Phillip Owens; Bo Liu; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-03-24       Impact factor: 8.311

9.  Single-cell RNA sequencing reveals the cellular heterogeneity of aneurysmal infrarenal abdominal aorta.

Authors:  Guizhen Zhao; Haocheng Lu; Ziyi Chang; Yang Zhao; Tianqing Zhu; Lin Chang; Yanhong Guo; Minerva T Garcia-Barrio; Y Eugene Chen; Jifeng Zhang
Journal:  Cardiovasc Res       Date:  2021-04-23       Impact factor: 10.787

10.  Self-healing polyurethane-elastomer with mechanical tunability for multiple biomedical applications in vivo.

Authors:  Chenyu Jiang; Luzhi Zhang; Qi Yang; Shixing Huang; Hongpeng Shi; Qiang Long; Bei Qian; Zenghe Liu; Qingbao Guan; Mingjian Liu; Renhao Yang; Qiang Zhao; Zhengwei You; Xiaofeng Ye
Journal:  Nat Commun       Date:  2021-07-20       Impact factor: 17.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.